Status:
ACTIVE_NOT_RECRUITING
Efficacy of Donepezil in Patients With Chronic Tinnitus
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions:
Tinnitus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Particip...
Detailed Description
Treatment effects were monitored using the Tinnitus Handicap Inventory (THI) and the Visual Analogue Scale (VAS).
Eligibility Criteria
Inclusion
- patients with chronic sensorineural tinnitus type
Exclusion
- pregnancy, arrhythmia, donepezil allergy, yelow dye allergy, otitis or any ear inflamatory diseases, patients taking any medication for dementia, convulsive diseases, asthma, patients taking any of these medications: carbamazepine, dexamethasone, phenobarbital, phenytoin, rifampicin, ketoconazole, quinidine.
Key Trial Info
Start Date :
November 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 9 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT07153991
Start Date
November 19 2021
End Date
December 9 2025
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade De São Paulo
São Paulo, São Paulo, Brazil, 04356080